Buscar por Palabras clave COVID19 pneumonia
Mostrando resultados 1 a 2 de 2
Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of.pdf.jpg](/retrieve/58b81418-66b3-4eeb-ac49-ef80935a3192/Experience%20with%20tocilizumab%20in%20severe%20COVID-19%20pneumonia%20after%2080%20days%20of.pdf.jpg) | 2020 | Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of
follow-up: A retrospective cohort study | Moreno-Pérez, Oscar; Andres, Mariano; LEON-RAMIREZ, JOSE-MANUEL; Sánchez-Payá, José; Rodríguez, Juan Carlos; Sánchez, Rosario; García Sevila, Raquel; Boix, Vicente; Gil, Joan; Merino, Esperanza | ![](/image/openAccess.png) |
![Hypokalemia as a sensitive biomarker of disease severity and the.pdf.jpg](/retrieve/a8c6ffbe-6548-45ca-b032-35b539a4adaf/Hypokalemia%20as%20a%20sensitive%20biomarker%20of%20disease%20severity%20and%20the.pdf.jpg) | 2020 | Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients | Moreno-Pérez, Oscar; LEON-RAMIREZ, JOSE-MANUEL; Fuertes Kenneally, Laura; Perdiguero, Miguel; Garcia-Navarro, Mar; Ruiz-Torregrosa, Paloma; Boix, Vicente; Gil, Joan; Merino, Esperanza; On behalf of COVID19-ALC Research Group | ![](/image/openAccess.png) |